Details of the Drug Formulaction

General Information of Drug Formulation (ID: F16124)

• Formulation Name: Oxcarbazepine 300 mg tablet
• Company: Supernus Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Oxcarbazepine	(DM5PU6O)	Epilepsy	8A60-8A68	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Eisenoxyd	(E00585)	56841934	Colorant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 2000	(E00649)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polyvinyl alcohol	(E00666)	Not Available	Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent